Analysts rate the chances of an immediate resumption of talks as low because AstraZeneca appears as committed as ever to its go-it-alone strategy
Source: Companies
Author
Harry Joiner
“… a dominant recruiter in the client-side multichannel ecommerce space …” — SearchEngineWatch.com